Yu Gu

2.1k total citations · 2 hit papers
65 papers, 1.5k citations indexed

About

Yu Gu is a scholar working on Oncology, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Yu Gu has authored 65 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Obstetrics and Gynecology and 13 papers in Surgery. Recurrent topics in Yu Gu's work include Endometrial and Cervical Cancer Treatments (13 papers), Ovarian cancer diagnosis and treatment (11 papers) and Fusion and Plasma Physics Studies (7 papers). Yu Gu is often cited by papers focused on Endometrial and Cervical Cancer Treatments (13 papers), Ovarian cancer diagnosis and treatment (11 papers) and Fusion and Plasma Physics Studies (7 papers). Yu Gu collaborates with scholars based in China, United States and Japan. Yu Gu's co-authors include Naiyer A. Rizvi, Rachel E. Sanborn, Scott Antonia, Ani Sarkis Balmanoukian, Joyson Karakunnel, Keith E. Steele, Sarah B. Goldberg, Rajesh Narwal, Wei Cang and Jamie E. Chaft and has published in prestigious journals such as Advanced Materials, Journal of Clinical Oncology and Hepatology.

In The Last Decade

Yu Gu

57 papers receiving 1.5k citations

Hit Papers

Safety and antitumour activity of durvalumab plus tremeli... 2016 2026 2019 2022 2016 2022 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study
    2016 481 citations Yu Gu et al. The Lancet Oncology profile →
  2. Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression
    2022 214 citations Lihua Chen, Yu Gu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Gu China 16 674 349 316 311 207 65 1.5k
Yuji Seo Japan 23 477 0.7× 320 0.9× 149 0.5× 549 1.8× 221 1.1× 107 1.5k
Neda A. Moatamed United States 17 609 0.9× 359 1.0× 127 0.4× 176 0.6× 313 1.5× 79 1.3k
Laura Pizzuti Italy 23 906 1.3× 454 1.3× 206 0.7× 333 1.1× 410 2.0× 96 1.7k
Antonella Romanini Italy 23 788 1.2× 436 1.2× 305 1.0× 274 0.9× 171 0.8× 73 1.7k
Muh‐Hwa Yang Taiwan 16 456 0.7× 465 1.3× 186 0.6× 161 0.5× 245 1.2× 56 1.3k
Antje Lebrecht Germany 23 610 0.9× 407 1.2× 215 0.7× 147 0.5× 305 1.5× 58 1.4k
Sofía Braga Portugal 17 931 1.4× 431 1.2× 150 0.5× 430 1.4× 357 1.7× 52 1.5k
Brian M. Nolen United States 21 577 0.9× 547 1.6× 282 0.9× 138 0.4× 364 1.8× 28 1.6k
Valentina Gambardella Spain 18 755 1.1× 474 1.4× 193 0.6× 471 1.5× 485 2.3× 85 1.5k

Countries citing papers authored by Yu Gu

Since Specialization
Citations

This map shows the geographic impact of Yu Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Gu more than expected).

Fields of papers citing papers by Yu Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Gu. The network helps show where Yu Gu may publish in the future.

Co-authorship network of co-authors of Yu Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Gu. A scholar is included among the top collaborators of Yu Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Gu. Yu Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Lihua, Weilin Chen, Xinran Li, et al.. (2025). Serum immune parameters as predictors for treatment outcomes in cervical cancer treated with concurrent chemo-radiotherapy. Chinese Medical Journal. 138(23). 3131–3138.
2.
Gao, Xing, et al.. (2025). Zinc Protoporphyrin Functions as a Ferroptosis Inducer to Activate Heme-BACH Axis and Potently Suppress IDH1-Mutant Gliomas. Antioxidants and Redox Signaling. 44(4-6). 145–163.
3.
4.
Gu, Yu, et al.. (2024). Intracardiac metastasis of gestational choriocarcinoma: a case report and literature review. BMC Pregnancy and Childbirth. 24(1). 19–19. 2 indexed citations
5.
6.
Li, Chen, et al.. (2023). The anti-PD-1 era of cervical cancer: achievement, opportunity, and challenge. Frontiers in Immunology. 14. 1195476–1195476. 16 indexed citations
7.
Luo, Wenhao, et al.. (2023). Does Oral Microbiota Have a Close Relationship with Pancreatic Cancer? A Systematic Review and Meta-Analysis. Annals of Surgical Oncology. 30(13). 8635–8641. 4 indexed citations
8.
9.
Gu, Yu, Dan Wang, Congwei Jia, et al.. (2023). Clinical characteristics and oncological outcomes of recurrent adult granulosa cell tumor of ovary: A retrospective study of seventy patients. Acta Obstetricia Et Gynecologica Scandinavica. 102(6). 782–790. 4 indexed citations
10.
11.
Chen, Lihua, Binhua Dong, Yu Gu, et al.. (2022). Low Level FLT3LG is a Novel Poor Prognostic Biomarker for Cervical Cancer with Immune Infiltration. Journal of Inflammation Research. Volume 15. 5889–5904. 6 indexed citations
12.
Li, Yan, Ying Shan, Huanwen Wu, et al.. (2022). 30-Year Experience With 22 Cases of Malignant Transformation Arising From Ovarian Mature Cystic Teratoma: A Rare Disease. Frontiers in Oncology. 12. 842703–842703. 13 indexed citations
13.
Gu, Yu, Yu Zhao, Zhanzhan Zhang, et al.. (2021). An Antibody-like Polymeric Nanoparticle Removes Intratumoral Galectin-1 to Enhance Antitumor T-Cell Responses in Cancer Immunotherapy. ACS Applied Materials & Interfaces. 13(19). 22159–22168. 19 indexed citations
14.
Cheng, Hongyan, Liju Zong, Yujia Kong, et al.. (2021). Camrelizumab plus apatinib in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia (CAP 01): a single-arm, open-label, phase 2 trial. The Lancet Oncology. 22(11). 1609–1617. 60 indexed citations
15.
Li, Siyi, Huifang Huang, Yan Li, et al.. (2020). A Comparison of Laparoscopies and Laparotomies for Radical Hysterectomy in Stage IA1-IB1 Cervical Cancer Patients: A Single Team With 18 Years of Experience. Frontiers in Oncology. 10. 1738–1738. 16 indexed citations
16.
Wang, Yun, et al.. (2018). Kinesio taping is superior to other taping methods in ankle functional performance improvement: a systematic review and meta-analysis. Clinical Rehabilitation. 32(11). 696866716–696866716. 40 indexed citations
17.
Gu, Yu, et al.. (2014). Surgical treatment of usual type vulvar intraepithelial neoplasia: a study at three academic hospitals. Chinese Medical Journal. 127(4). 784–786. 4 indexed citations
18.
Ding, Songming, Wu Zhang, Zhiyuan Xu, et al.. (2013). Induction of an EMT-like transformation and MET in vitro. Journal of Translational Medicine. 11(1). 164–164. 18 indexed citations
19.
Li, Xiaochuan, et al.. (2012). A multicenter study of the clinical characteristics of usual‐type vulvar intraepithelial neoplasia in China. International Journal of Gynecology & Obstetrics. 117(1). 18–22. 3 indexed citations
20.
Zhou, Hai, Yan Hu, Xin Li, et al.. (2011). Suppression of vascular endothelial growth factor via siRNA interference modulates the biological behavior of human nasopharyngeal carcinoma cells. Japanese Journal of Radiology. 29(9). 615–622. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuji Seo Breakdown of academic impact, for papers by Neda A. Moatamed Breakdown of academic impact, for papers by Laura Pizzuti Breakdown of academic impact, for papers by Antonella Romanini Breakdown of academic impact, for papers by Muh‐Hwa Yang Breakdown of academic impact, for papers by Antje Lebrecht Breakdown of academic impact, for papers by Sofía Braga Breakdown of academic impact, for papers by Brian M. Nolen Breakdown of academic impact, for papers by Valentina Gambardella
Rankless by CCL
2026